19th July 2019

Pemberton acts as sole lender to support expansion plans of Laboratorios Larrasa


Overview

Pemberton, the asset manager backed by one of Europe’s largest insurers, Legal & General Group PLC, today announces that it has acted as a sole lender for Spanish clinical and genetic laboratory business, Laboratorios Larrasa, as it continues its impressive growth plans.

Founded in 2002 and headquartered in La Albuera, Spain, Laboratorios Larrasa is an international leading clinical and genetic laboratory business. The capital provided by Pemberton comprises a Term Loan and a Capex Facility that will be used both to refinance the business’ existing debt and to support expansion of its operations, specifically its work in identifying genetic markers in animals.

Laboratorios Larrasa was advised by Meridium GM Partners, Deloitte, KPMG and PwC. Pemberton was advised by DLA Piper.

Laboratorios Larrasa has undergone significant growth since its founding back in 2002 and we are pleased to be providing new capital for the business as it enters the next stage of its development. This deal marks Pemberton’s 4th transaction in Spain this year, as we continue to embed ourselves in the market.

– Cassandra Fahy, Managing Director of Origination, UK & Ireland at Pemberton

This transaction is a very important milestone in the journey of the Company as we seek to better serve our key customers and expand our operations. We considered various financing routes and decided to partner with Pemberton due to the combination of their thoughtful structuring, focus on understanding the business and ability to provide long-term capital.

– José Larrasa, CEO and Founder of Laboratorios Larrasa

About the author

Cassandra Fahy

Managing Director, Origination UK & Ireland